Crossmark

Differences in axillary response and treatment implications in HER2 positive node positive breast cancer during neoadjuvant HER2 targeted dual therapy

Crossref DOI link: https://doi.org/10.1038/s41598-024-78176-x

Published Online: 2024-11-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mou, Exian

Ji, Juan

Liu, Shiwei

Shu, Lan

Zou, Liqun

Li, Zhuoxuan
Funding

Funding for this research was provided by:

Sichuan Provincial Science and Technology Support Program (2023YFS0103)

Sichuan Provincial Science and Technology Support Program (2023YFS0103)

Sichuan Provincial Science and Technology Support Program (2023YFS0103)

Sichuan Anti-Cancer Association Program (XH2022515)

Sichuan Anti-Cancer Association Program (XH2022515)

Sichuan Anti-Cancer Association Program (XH2022515)
License Information

Text and Data Mining valid from 2024-11-01

Version of Record valid from 2024-11-01
More Information

Article History

Received: 22 July 2024

Accepted: 29 October 2024

First Online: 1 November 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below